Berahovich, R., Zhou, H., Xu, S., Wei, Y., Guan, J., Guan, J., Harto, H., Fu, S., Yang, K., Zhu, S., Li, L., Wu, L. and Golubovskaya, V. (2018). CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth. Cancers, [online] 10(9). Available at: https://www.ncbi.nlm.nih.gov/pubmed/30208593 [Accessed 28 May 2021].
Bosco, E.E., Christie, R.J., Carrasco, R., Sabol, D., Zha, J., DaCosta, K., Brown, L., Kennedy, M., Meekin, J., Phipps, S., Ayriss, J., Du, Q., Bezabeh, B., Chowdhury, P., Breen, S., Chen, C., Reed, M., Hinrichs, M., Zhong, H. and Xiao, Z. (2018). Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer. Oncotarget, [online] 9(33), pp.22960–22975. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29796165 [Accessed 28 May 2021].
Elster, N., Toomey, S., Fan, Y., Cremona, M., Morgan, C., Weiner Gorzel, K., Bhreathnach, U., Milewska, M., Murphy, M., Madden, S., Naidoo, J., Fay, J., Kay, E., Carr, A., Kennedy, S., Furney, S., Mezynski, J., Breathhnach, O., Morris, P. and Grogan, L. (2018). Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer. Therapeutic Advances in Medical Oncology, [online] 10, p.1758835918778297. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30023006 [Accessed 28 May 2021].
Huang, Y.-H., Lin, K.-H., Yu, J.-S., Wu, T.-J., Lee, W.-C., Chao, C.C.-K. ., Pan, T.-L. and Yeh, C.-T. (2018). Targeting HSP60 by subcutaneous injections of jetPEI/HSP60-shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth. Molecular Carcinogenesis, [online] 57(9), pp.1087–1101. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29672920 [Accessed 28 May 2021].
Ji, D., Zhan, T., Li, M., Yao, Y., Jia, J., Yi, H., Qiao, M., Xia, J., Zhang, Z., Ding, H., Song, C., Han, Y. and Gu, J. (2018). Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer. Stem Cell Reports, [online] 11(6), pp.1506–1522. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30449704 [Accessed 28 May 2021].
Kim, Y., Kang, B.-J., Kim, W.H., Yun, H.-S. and Kweon, O.-K. (2018). Evaluation of Mesenchymal Stem Cell Sheets Overexpressing BMP-7 in Canine Critical-Sized Bone Defects. International Journal of Molecular Sciences, [online] 19(7). Available at: https://www.ncbi.nlm.nih.gov/pubmed/30018197 [Accessed 28 May 2021].
Kong, F., Deng, X., Kong, X., Du, Y., Li, L., Zhu, H., Wang, Y., Xie, D., Guha, S., Li, Z., Guan, M. and Xie, K. (2018). ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF. Oncogene, [online] 37(45), pp.5982–5996. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29985481 [Accessed 28 May 2021].
Lian, W.-S., Ko, J.-Y., Chen, Y.-S., Ke, H.-C., Wu, S.-L., Kuo, C.-W. and Wang, F.-S. (2018). Chaperonin 60 sustains osteoblast autophagy and counteracts glucocorticoid aggravation of osteoporosis by chaperoning RPTOR. Cell Death & Disease, [online] 9(10), p.938. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30224697 [Accessed 28 May 2021].
Lv, B., Ma, L., Tang, W., Huang, P., Yang, B., Wang, L., Chen, S., Gao, Q., Zhang, S. and Xia, J. (2018). FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, [online] 48(1), pp.158–172. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30001540 [Accessed 28 May 2021].
Ma, M., Zhao, R., Yang, X., Zhao, L., Liu, L., Zhang, C., Wang, X. and Shan, B. (2018). The clinical significance of Mda-7/IL-24 and C-myb expression in tumor tissues of patients with diffuse large B cell lymphoma. Experimental and Therapeutic Medicine, [online] 16(2), pp.649–656. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30112030 [Accessed 28 May 2021].
Qian, D., Song, G., Ma, Z., Wang, G., Jin, L., Hu, M., Song, Z. and Wang, X. (2018). MicroRNA-9 modified bone marrow-derived mesenchymal stem cells (BMSCs) repair severe acute pancreatitis (SAP) via inducing angiogenesis in rats. Stem Cell Research & Therapy, [online] 9(1), p.282. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30359310 [Accessed 28 May 2021].
Sekiba, K., Otsuka, M., Ohno, M., Yamagami, M., Kishikawa, T., Suzuki, T., Ishibashi, R., Seimiya, T., Tanaka, E. and Koike, K. (2019). Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction. Cellular and Molecular Gastroenterology and Hepatology, [online] 7(2), pp.297–312. Available at: https://www.sciencedirect.com/science/article/pii/S2352345X18301565 [Accessed 28 May 2021].
Song, Q., Ji, Q., Xiao, J., Li, F., Wang, L., Chen, Y., Xu, Y. and Jiao, S. (2018). miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1. Molecular Therapy. Nucleic Acids, [online] 13, pp.154–163. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171160/ [Accessed 4 Jun. 2020].
Tse, A.P.-W., Sze, K.M.-F., Shea, Q.T.-K., Chiu, E.Y.-T., Tsang, F.H.-C., Chiu, D.K.-C., Zhang, M.S., Lee, D., Xu, I.M.-J., Chan, C.Y.-K., Koh, H.-Y., Wong, C.-M., Zheng, Y.-P., Ng, I.O.-L. and Wong, C.C.-L. (2018). Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. Oncogenesis, [online] 7(5), p.44. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29799025 [Accessed 28 May 2021].
Wang, L., Cai, H., Hu, Y., Liu, F., Huang, S., Zhou, Y., Yu, J., Xu, J. and Wu, F. (2018). A pharmacological probe identifies cystathionine β-synthase as a new negative regulator for ferroptosis. Cell Death & Disease, [online] 9(10). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158189/ [Accessed 16 Dec. 2020].
Wu, X., Zhao, J., Ruan, Y., Sun, L., Xu, C. and Jiang, H. (2018). Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer. Cell Death & Disease, [online] 9(11). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207573/ [Accessed 3 May 2021].
Xiang, S., Chen, H., Luo, X., An, B., Wu, W., Cao, S., Ruan, S., Wang, Z., Weng, L., Zhu, H. and Liu, Q. (2018). Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling. Journal of experimental & clinical cancer research: CR, [online] 37(1), p.184. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30081934 [Accessed 28 May 2021].
Zhao, X., Yang, C., Wu, J. and Nan, Y. (2018). ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma. OncoTargets and Therapy, [online] 11, pp.7569–7578. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30464505 [Accessed 28 May 2021].